Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702Akira Inoue, Toshihiro Nukiwa, Hiroshi Watanabe et al.|Lung Cancer|2015Cited by 35
Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 TrialsToshiyuki Harada, Masaharu Nishimura, Toraji Amano et al.|Frontiers in Pharmacology|2018Cited by 19
Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancerAya Suzuki, Toshihiro Nukiwa, Makoto Maemondo et al.|Cancer Treatment and Research Communications|2017Cited by 6
A phase I/II study of gemcitabine (GEM) and carboplatin (CBDCA) biweekly combination chemotherapy for inoperable stage IIIB, IV non-small-cell lung cancer (NSCLC) (final report)Yukihiro Hasegawa, Kazuhiro Okumura, Shingo Takanashi et al.|Journal of Clinical Oncology|2005Cited by 3
A phase I study of biweekly combination chemotherapy with gemcitabine (GEM) and carboplatin (CBDCA) for inoperable stages IIIB and IV non-small-cell lung cancer (NSCLC)Yukihiro Hasegawa, Kazuhiro Okumura, H. Nakagawa et al.|Journal of Clinical Oncology|2004Cited by 1